SCHEMBL7430233

SCHEMBL7430233

COC(=O)c1ccc(C(=O)Nc2ccc(C)cc2OCCCCN2C(=O)c3ccccc3C2=O)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.58
POLB P06746 1/20 0.58
KMT2A Q03164 5/20 0.49
MEN1 O00255 4/20 0.49
MAPT P10636 3/20 0.48
HSP90AA1 P07900 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPK1 P28482 2/20 0.47
HPGD P15428 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.45
CA9 Q16790 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474710 0.86 ALDH1A1 (0.54) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL7417588 0.83 HTT (0.47) ALDH1A1POLBMAPTHSP90AA1HTT
SCHEMBL8265929 0.77 RAB9A (0.59) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL7425247 0.77 ALDH1A1 (0.43) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL9798906 0.75 MAPK1 (0.69) ALDH1A1POLBMAPTHSP90AA1HTT
SCHEMBL8611049 0.74 ALDH1A1 (0.44) ALDH1A1POLBKMT2AMEN1HPGD
SCHEMBL7339504 0.74 AVPR2 (0.43) ALDH1A1POLBKMT2AMEN1
SCHEMBL7426873 0.73 POLB (0.44) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL25040532 0.73 ALDH1A1 (0.53) ALDH1A1POLBMAPTHSP90AA1HTT
SCHEMBL29729346 0.73 ALDH1A1 (0.53) ALDH1A1POLBMAPTHSP90AA1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed